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Abstract  
Background 
Low back pain (LBP) is a major health problem, having a substantial effect on peoples’ quality of life 
and placing a significant economic burden on health care systems and, more broadly, societies. 
Many interventions to alleviate LBP are available but their cost-effectiveness is unclear.  
Objectives 
To identify, document and appraise studies reporting on the cost-effectiveness of non-invasive and 
non-pharmacological treatment options for LBP.  
Methods  
Relevant studies were identified through systematic searches in bibliographic databases (EMBASE, 
MEDLINE, PsycINFO, Cochrane Library, CINAHL and NHS Economic Evaluation Database), ‘similar 
article’ searches and reference list scanning. Study selection was carried out by three assessors, 
independently. Study quality was assessed using the Consensus on Health Economic Criteria 
checklist. Data were extracted using customized extraction forms.  
Results 
Thirty-three studies were identified. Study interventions were categorised as: (i) combined physical 
exercise and psychological therapy, (ii) physical exercise therapy only, (iii) information and education 
and,(iv) manual therapy . Interventions assessed within each category varied in terms of their 
components and delivery. In general, combined physical and psychological treatments, information 
and education interventions and manual therapies appeared to be cost-effective when compared 
with the study-specific comparators. There is inconsistent evidence around the cost-effectiveness of 
physical exercise programmes as a whole, with yoga, but not group exercise, being cost-effective.  
Conclusions 
The identified evidence suggests that combined physical and psychological treatments, medical 
yoga, information and education programmes, spinal manipulation and acupuncture are likely to be 
cost-effective options for LBP.   
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Key points for decision makers 
 Differences across studies due to diversity in comparators and methods employed limit the 
comparability of studies and hinder drawing conclusions. 
 Identified studies reported a variety of outcomes, most often incremental cost per quality-
adjusted life year, but also additional cost per improvement in pain, quality of life or reduction in 
work absenteeism.  
 Evidence suggests that combined physical and psychological treatments, medical yoga, 
information and education programmes, spinal manipulation and acupuncture are likely to 
be cost-effective options for LBP.  Active exercise programmes are more equivocal in terms 
of cost-effectiveness.  
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1. Introduction  
Low back pain (LBP) is one of the commonest health problems, with a lifetime prevalence of 80-85% 
[1]. In 2010, LBP ranked first in causes of global years lived with disability (defined as ‘life lived in less 
than ideal health’), and third for global disability-adjusted life years (defined as ‘the sum of years of 
life lost due to premature mortality and years lived with disability’) for non-communicable diseases 
[2, 3]. 
The economic burden of LBP is equally substantial. Estimating this burden has been the focus of a 
number of studies over the past 15 years, most of which have a particular emphasis on North 
America and Europe [4-8]. A UK study published in 2000 (using 1998 prices) reported an upper 
estimate for the societal impact of LBP-related health service resource use and periods of work 
absence to be in excess of £12 billion. This estimate comprised £1.6 billion incurred through the 
provision of direct health care resources, £1.6 billion related to informal care and £9.1 billion 
associated with production losses (sometimes referred to as ‘indirect’ costs) due to morbidity. In the 
US, of the $90.7 billion of total (i.e. both back pain related and unrelated) health care expenditures 
incurred by individuals with LBP in 1998, Luo and colleagues [6] estimated that $26.3 billion were 
attributable to LBP. International evidence has provided some consistent findings; indirect costs 
represent the majority of overall costs, the provision of care by primary care practitioners and 
physiotherapists contributes 25-30% of direct healthcare costs, and chronic LBP patients account for 
a large proportion of total health care costs [4, 5, 8]. 
It is evident that significant savings—to both the health care system and society as a whole—are 
possible through improved management of LBP. However, there is a paucity of evidence on the cost-
effectiveness of different LBP treatments. This is evident in the fact that primary care LBP 
researchers have explicitly identified the absence of such evidence, with consideration of ‘cost-
effectiveness’ having recently been named as a leading research priority [9].  
Many therapies are available for treatment of LBP [10]. Clinicians’ recommendations for appropriate 
therapies can vary substantially, [11, 12] and there is considerable uncertainty regarding the 
respective value of such treatments and interventions [13]. The aim of this systematic review was to 
identify, document and appraise studies reporting on the cost-effectiveness of non-invasive and 
non-pharmacological interventions for LBP.  
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2. Methods 
2.1 Study identification 
We searched for economic evaluations of non-invasive and non-pharmacological interventions in six 
major electronic bibliographic databases (EMBASE, MEDLINE, PsycINFO, Cochrane Library, CINAHL 
and NHS Economic Evaluation Database). The review’s protocol was not published. Searches covered 
the period from January 2000 to July 2015, and were informed by a list of safe and potentially 
beneficial non-invasive and non-pharmacological interventions included in guidelines published by 
the National Institute for Health and Care Excellence (NICE) in the UK [13] and the American Pain 
Society/American College of Physicians (APS/ACP) in the US [10]. These included various combined 
physical exercise and psychological treatments, physical exercise interventions, manual therapy 
programmes, and information and education programmes (see Online Resource 1). Acupuncture 
was included as a non-invasive intervention in line with the draft LBP guidance published by NICE in 
2016 [14]. Employed search strategies comprised combinations of key words, synonyms, term 
variants, expressions and Medical Subject Heading (MeSH) terms. A sample search strategy can be 
found in the electronic supplementary material (Online Resource 1). Supplementary searches were 
carried out through a review of reference lists of key articles and previous systematic reviews known 
to the research team, through screening reference lists of articles included in the study and through 
carrying out ‘similar article’ searches in MEDLINE (via the PubMed interface).  
2.2. Study selection 
All identified articles were considered against a list of predetermined inclusion and exclusion criteria 
(Online Resource 1). Selection of articles was carried out by three reviewers (SQ, LA, and PK) 
independently. Disagreement in inclusion or exclusion was discussed between the reviewers. 
Selection was carried out in two stages. The first stage aimed to filter out clearly irrelevant 
publications and involved applying the inclusion criteria on each article’s title and abstract. 
Publications which met the inclusion criteria at the first stage, as well as articles for which an 
exclusion or inclusion decision could not be made on the basis of their title and abstract alone, were 
forwarded to the second stage, where they were judged on the basis of their full text.  
To identify and assess the available cost-effectiveness evidence, we targeted different types of 
economic evaluation studies. Economic evaluations are defined as comparative analyses of 
alternative technologies, interventions or programmes in terms of both their costs and 
consequences [15]. Three forms of economic evaluation are typically identified: cost-effectiveness 
analyses (CEA), cost-utility analyses (CUA), and cost-benefit analyses (CBA). In all three forms of 
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economic analysis, costs are measured in monetary terms. In CEA, consequences are captured as a 
simplistic, single, natural unit of outcome. In CUA, consequences are expressed in terms of quality 
adjusted life years (QALYs). QALYs are calculated by adjusting the time spent in a particular health 
state by the utility or disutility associated with that specific health state.  One QALY is equivalent to 
one year of full health. Finally, in CBA the utility or disutility associated with a treatment or 
intervention is expressed as a monetary value. 
2.3 Extraction, quality assessment and synthesis of relevant information 
A customised data extraction form was created to record information on relevant aspects, such as 
bibliographic information (author(s), journal and year of publication), general information (country, 
population, interventions and comparators), methodological characteristics (type of economic 
evaluation, type of analysis, perspective, included costs and reported outcomes). Data were 
extracted by one reviewer (SQ) and were checked and verified by four of the reviewers (LA, DW, PK, 
and HM). Quality assessment of the identified studies was carried out by two reviewers (LA and SQ) 
using the Consensus on Health Economic Criteria (CHEC-list) checklist [16]. The CHEC-list was 
developed to provide a means of obtaining insights into the methodological quality of economic 
evaluation studies summarised in systematic reviews. The list has been used widely and is 
recommended in Cochrane reviews as a means of informing appraisal of the methodological quality 
of economic evaluations [17]. The list comprises 19 questions which were developed and agreed by 
23 international experts over three rounds of a Delphi consensus building exercise. Each item of the 
CHEC-list was formulated as a question that can be answered by yes or no. The checklist does not 
make provisions for the calculation of numerical scores that summarise a study’s quality, thus no 
such scores were calculated.  
Negative answers to checklist items do not necessarily concede poor practice or result in bias. While 
no identified studies were discarded on the grounds of poor methodology, relevant limitations are 
explicitly discussed in the following section. Studies were grouped thematically, according to the 
type of the intervention they assess. Narrative synthesis was used to analyse, summarise and 
present the information provided in each of the selected articles.  
3. Results 
A total of 891 unique records identified through searches in bibliographic databases and other 
sources were considered for inclusion. Scanning these records on the basis of their title and abstract 
led to exclusion of 802 irrelevant records (stage 1). Full text assessment of the 89 potentially 
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relevant studies resulted in the exclusion of a further 56 records. The remaining 33 studies [18-50] 
comprised the final set of studies that formed the basis for this review. The PRISMA flowchart 
summarising the selection process is given in Figure 1.  
3.1 Overview 
All of the identified studies were carried out in developed countries and were published between 
2002 and 2015. Of these studies, 26 were conducted in Europe (United Kingdom: 14, Norway: 3, 
Germany: 2, The Netherlands: 2, Finland: 2, Sweden: 1; Denmark: 1, Switzerland: 1), while the 
remaining seven studies were carried out in North America (United States: 4, Canada: 2) and Asia 
(South Korea: 1). Interventions assessed in the identified studies were categorised into the following 
groups: (i) combined physical exercise and psychological treatment (n=12), ii) physical exercise 
therapy (n=6), iii) manual therapy (n=10), and iv) information and education (n=5).  
Characteristics of the identified studies, including the compared interventions, employed 
methodology and economic evaluation outcomes, are given in Table 2. Twenty-two studies 
undertook and reported CUA, in all of which outcomes were measured in terms of QALYs. Four 
studies were CEA [21, 24, 25, 29], typically looking into outcomes such as reduction in disability or 
pain. Two studies were CBA [19, 20], three reported both a CUA and a CEA [34, 37, 38] and two 
reported a CEA and a CBA [18, 46]. 
Indications on the methodological quality of the identified studies were obtained through 
assessment against the 19 items (questions) of the CHEC-list quality assessment checklist [16]. 
Answers to CHEC-list questions are presented in Table 1. Positive answers to these questions are 
considered to be indicative of good practice in undertaking and reporting economic evaluations. In 
all of the identified studies, the number of positive (‘yes’) answers exceeded those of negative or not 
applicable responses. Many of the negative responses were given to questions related to i) 
subjecting uncertain variables to sensitivity analysis, ii) discussing the generalisability of the obtained 
results, and iii) identifying and measuring all appropriate and relevant costs. While sensitivity 
analyses were present in the majority of the studies, these would often not target variables that the 
authors identify to be uncertain. An extensive discussion of findings’ generalisability was often not 
present in cases where the authors conducted an evaluation of a particular, tailored programme 
provided by a specific payer. Last, questions related to identification and measurement of all 
appropriate and relevant costs received negative responses when costs relevant to the chosen 
perspective (e.g. productivity loss when a societal perspective was adopted) were not included.  
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In the majority of the studies, economic evaluation was carried out alongside clinical studies, most 
often randomised clinical trials (RCTs) (n=29). One study was based on both a randomised and a non-
randomised trial [24] and two studies drew data from a prospective, sequential comparison of 
separate patient cohorts [47, 50]. Two studies synthesised information from different sources 
through decision analytic models [40, 49].  
Typically, the time horizon for the analysis was 12 months and was dictated by the maximum follow 
up in clinical studies which provided data for the economic evaluations. Five studies reported results 
over a 6 month time horizon [23, 28, 30, 35, 50] and five studies looked at costs and benefits 
accruing between 12 and 24 months post intervention [19, 25, 26, 31, 38]. Only four studies 
reported results over time horizons longer than 24 months. Of these, two studies used data from 
clinical studies with long follow-up [18, 20] and two studies estimated cost-utility results by 
extrapolating over long time horizons using decision analytic models [40, 49]. In line with 
recommendations, discounting was carried out to account for the effect of preferential timing in six 
of the 10 [19, 20, 26, 31, 40, 49] studies which had a follow-up time greater than 12 months. 
Discounting was not explicitly mentioned in the remaining four studies [18, 21, 24, 33]. 
3.2 Findings of identified studies 
Findings of each study, grouped according to the nature of the compared interventions, are given in 
the text below.  
3.2.1 Combined physical exercise and psychological treatment interventions 
Twelve studies looking into the cost-effectiveness of combined physical and psychological 
interventions were identified. Rogerson et al. [42] (USA, societal perspective) focused on a patient 
group with comparatively severe LPB symptoms, targeting patients screened to identify those at 
high risk of chronic disability with an intervention combining cognitive behavioural therapy (CBT) 
and physical therapy. From a societal perspective, the intervention dominated as a treatment 
strategy, with greater QALY gain and lower total costs. Similarly, Lamb et al. [41] (UK, health care 
system perspective) found that although the addition of CBT was associated with higher costs 
(compared to usual care and from a healthcare provider perspective), the favourable QALY gain 
associated with CBT resulted in a low incremental cost-effectiveness ratio (ICER) of £1,786 per QALY 
(valuation year: 2008) and a high probability of CBT being cost-effective.  
Norton et al. [49] (USA, commercial payer perspective) constructed a decision analytic model to 
explore the short and long term cost and QALYs of CBT. Key inputs in this analysis, including the 
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likelihood of improvement and quality of life (QoL) values, were obtained from the RCT reported in 
Lamb et al. [41], as well as from the existing literature. Using a US healthcare payer perspective, 
Norton et al. [49] estimated the ICER for CBT versus usual care to be $7,197 per QALY in the first 
year, and $5,855 per QALY over a 10 year time horizon (valuation year 2008). 
Four studies evaluated the use of the Keele risk stratification tool, a prognostic screening method 
which was developed to categorise patients by LBP prognosis to different targeted physiotherapy 
treatment regimes. The initial StarT Back RCT aimed to assess the effectiveness and cost-
effectiveness of the tool [43, 45] (UK, health care system and societal perspectives). This was 
followed by the IMPaCT Back Study, which sought to determine the effect of implementing the tool 
on physicians’ choices and patient outcomes [47, 50] (UK, health care system and societal 
perspectives). In addition to evidence on health outcomes, these studies offered patient level data 
on use of NHS health care resources, private patient payment and productivity losses. The initial 
study [43, 45] found the intervention to be cost-effective compared to current practice across all 
three risk defined sub-groups, with results ranging from dominance for the medium-risk group to a 
low ICER of £463 per QALY (valuation year: 2008) for the high-risk group [45]. The implementation 
study [47, 50] found the Keele stratification tool was cost-effective (resulting in cost savings and 
QALY gains of £124 and 0.023, respectively) only for the high-risk patients [50] (valuation year: 
2008). 
Four of the studies of CBT or interventions containing some psychosocial element report results 
which are ambiguous or open to debate. Whitehurst et al. [34] (UK, health care perspective) report a 
slightly greater clinical benefit from physical therapy than from a brief pain management 
programme (BPM) targeting psychosocial factors, but lower mean healthcare costs for the latter. In 
this study, the most cost-effective option is physical therapy (with a cost per QALY of £2,362 
(valuation year: 2001)), though the authors suggest that BPM may be acceptable as an additional 
treatment option, if provided in fewer sessions [34].  
Schweikert et al. [28] (Germany, societal perspective) set out to assess the cost-effectiveness of 
providing CBT in addition to usual care in patients with chronic LBP in Germany. This study, which 
had a follow-up period of just six months, showed no statistically significant difference in treatment 
costs between CBT and standard therapy, and no significant differences in health outcomes, 
expressed in QALYs. However, due to differences in indirect costs described as being of borderline 
significance, the authors indicated that the intervention would be cost saving from a societal 
perspective. 
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Similarly, Johnson et al. [33] (UK, health care system perspective) conducted a trial-based economic 
evaluation to determine the impact of a CBT-based exercise and education programme on resource 
use, costs and patient outcomes. While the intervention led to a small, non-significant reduction in 
pain and disability, use of resources and costs were low, resulting in an ICER of £5000 per additional 
QALY (valuation year: 2003). However, the authors suggest that changes detected in QALYs may 
have been due to bias associated with those patients who had consciously opted into CBT.  
Skouen et al. [19] (Norway, societal perspective) carried out a CBA where the benefits of treatment 
were expressed in terms of productivity gains. The authors found that a light multidisciplinary 
treatment programme resulted in net benefit for men, but that there was no significant treatment 
effect for women. No significant differences in costs and benefits were found for a more substantial 
and extensive multidisciplinary treatment programme.  
In the last study in this group, Critchley et al. [31] (UK, health care system perspective) sought to 
compare the effectiveness and cost-effectiveness of different types of physiotherapy for patients 
with chronic LBP. Three interventions were compared against each other: usual outpatient 
physiotherapy, spinal stabilisation classes and physiotherapist-led pain management classes which 
were informed by a cognitive-behavioural approach. The authors found all three physiotherapy 
programmes to result in reduced disability (measured by the Roland Disability Questionnaire), 
improved health-related QoL (measured by EQ-5D), and fewer days off work. In relation to cost-
effectiveness, physiotherapist-led pain management appeared to be less costly and marginally more 
effective than the other interventions. 
3.2.2 Physical exercise therapy interventions 
Six studies assessed the health and economic benefits of exercise and physical activity programmes. 
All these studies conducted and reported CUAs, with Smeets et al. [38] also reporting a CEA (cost per 
reduction in disability). 
Two studies assessed the costs and benefits of yoga, both of which were carried out on the basis of 
data collected from randomised controlled trials. In the first of them, Aboagye et al. [48] (Sweden, 
employer and societal perspectives) found yoga to be cost-effective from the employer’s perspective 
compared to exercise therapy and self-care advice. From the employer’s perspective, the authors 
estimated the ICER for yoga to be as low as EUR 4,984 per QALY (valuation year: 2011) when 
compared to self-care advice, and found that yoga is less costly and of equivalent effectiveness when 
compared to exercise. When considering productivity costs as part of a societal perspective, 
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Aboagye et al. [48] found that yoga would be a cost-effective option if decision makers deem that a 
QALY is worth EUR 11,500.  
In the second study, Chuang et al. [44] (UK, health care system and societal perspectives) compared 
yoga in addition to usual care against usual care alone. From the health care perspective, the 
authors found yoga to be cost effective if decision makers were willing to pay up to £20,000 for an 
additional QALY (ICER of £13,606 per QALY, valuation year: 2008), while from a societal perspective 
yoga is associated with cost savings and a greater number of QALYs. Both studies were conducted in 
Europe (Sweden and the UK respectively), and as with the exercise studies, both adopted a 12 
month follow-up. 
Two studies looked at the cost-effectiveness of group exercise therapy. Henchoz et al. [39] 
(Switzerland, societal perspective) compared a 12 week long exercise programme supervised by a 
sports therapist against usual care comprising advice to exercise regularly, both of which were 
offered as a follow-up to an outpatient multidisciplinary rehabilitation programme. While the 
exercise programme resulted in improved disability and trunk muscle endurance, these 
improvements did not lead to economic benefits. The authors estimated that the addition of 
exercise as a follow up to a multidisciplinary programme resulted in an ICER of EUR 79,270 (valuation 
year: 2005) and concluded that group exercise is not cost-effective given commonly cited values of 
decision makers’ willingness-to-pay (WTP) for a QALY. In a study comparing intensive group training 
against usual physiotherapy care, van der Roer et al. [37] (Netherlands, societal perspective) found 
that group exercise resulted in higher costs and no significant differences in QALYs as compared to 
standard physiotherapy. A main driver of the higher cost was the increased use of secondary and 
alternative care services in the exercise group.  
Smeets et al. [38] (Netherlands, societal perspective) assessed the cost per one-point improvement 
in disability and cost per QALY for the comparison between: (i) 10 weeks of physical training 
(including aerobic training and muscle strengthening), (ii) 10 weeks of gradual assumption of patient 
relevant activities and problem solving training, and (iii) a combination of the two programmes. 
Findings suggested that whilst combined treatment was not cost-effective, graded activity plus 
problem solving training delivered as a single intervention was marginally more effective (in terms of 
QALYs and reduction in disability) than the active physical treatment programme and the 
combination programme, as it was associated with lower direct and indirect costs. 
Rivero-Arias et al. [27] (UK, health care and societal perspectives) sought to evaluate the potential 
costs and benefits of physiotherapy treatment compared to usual advice given by a physiotherapist 
12 
 
for patients with subacute and chronic LBP. The analysis, which makes use of data from a 
randomised controlled trial, reported no significant differences QoL between the physiotherapy and 
advice groups, though they found physiotherapy treatment to be associated with significantly higher 
out-of-pocket expenditures for patients. Despite the relatively low ICER of physiotherapy treatment 
of £3,890 per QALY (valuation year: 2004), the higher out-of-pocket expenditures were a main 
influence in the authors’ conclusion that physiotherapist advice should be the treatment of choice in 
patients with the particular level of LBP severity.  
3.2.3 Information and education interventions 
Five studies looked at the costs and benefits of interventions involving education and provision of 
information. Loisel et al. [18] (Canada, insurance provider perspective) compared clinical 
rehabilitation, an occupational intervention comprising visits to an occupational therapist and 
participatory work with ergonomists, and a combination of the above (Sherbrooke model) against 
standard care. Two analyses were undertaken: a CEA and a CBA. For the former, the authors 
compared the additional costs per number of days on full benefits (full compensation) due of 
absence from work, and found that the greatest savings were associated with the occupational 
intervention. For their CBA analysis, Loisel et al. [18] subtracted the additional gains from avoided 
work absence between each intervention and standard care, from the additional cost of the 
intervention as compared to standard care. The authors found that the Sherbrook model results in 
mean savings of $18,585 per worker over 6.4 years (valuation year: 1998), although they 
acknowledge that there were no statistically significant differences in absenteeism avoided between 
the four interventions.  
A similar outcome—the net monetary value due to avoided absenteeism—was explored in the study 
by Molde Hagen et al. [20] (Norway, societal perspective). This study compared a spine clinic 
examination and provision of advice and information against usual treatment in primary care. The 
authors used a CBA framework to explore the long term economic returns of the intervention, in 
terms of productivity gains due to reduced absenteeism. Findings suggest that spinal clinic care and 
advice led to significantly fewer days of sick leave at 1 and 3 year follow-up points, which translated 
to economic returns of approximately $3,500 per person (valuation year: 1995) (though a net 
benefit value of $2,822 per person is given in the abstract).  
Strong and colleagues [29] (USA, insurer perspective) set out to evaluate the effectiveness and cost-
effectiveness of psychologist-led and lay person-led back pain educational sessions. Information on 
resource use and effectiveness was obtained from two cohorts of primary care patients participating 
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in two RCTs. Costs included in the study related to expenditures for delivering the interventions and 
resource use within primary care. Effectiveness was measured in terms of the number of low impact 
days, i.e. days during which patients were satisfied with the level of back pain they experienced. 
Both the psychologist and lay person led interventions resulted in additional low-impact days. The 
additional cost per low-impact day was found to be $9.70 and $6.13 (valuation year not stated) for 
the lay and psychologist-led interventions. 
In a more recent study, Jensen et al. [46] (Denmark, health care system, taxpayer and societal 
perspectives) looked at the cost-effectiveness of interventions aimed to enabling LBP patients who 
have been on sick leave to return to work. The authors compared a brief intervention comprising 
initial clinical examination followed by advice to increase physical activity against a multidisciplinary 
intervention, which, in addition to these components, included a tailored plan to facilitate return to 
work, co-ordinated by a case manager. Two analyses were conducted: a CEA from the perspective of 
the health care system in Denmark to determine the additional cost per a one-week reduction in sick 
leave, and a CBA, which adopted a societal perspective and included costs borne by the health care 
system and productivity losses. The authors [46] reported that the multidisciplinary intervention was 
more costly that the brief intervention, and, in general, did not result in fewer days of sick leave.  
On the premise that psychosocial factors may play a part in preventing LBP from becoming chronic, 
Jellema et al. [32] (Netherlands, societal perspective) assessed the costs and effectiveness of a 
minimal intervention strategy aimed at psychosocial factors compared to usual care in patients with 
sub-acute LBP. The authors found no statistically significant differences in either costs or QALYs in 
their analysis based on complete trial data, which gave a relatively high ICER of EUR 47,348 
(valuation year: 2002) for the minimal intervention strategy. These findings prompted the authors to 
suggest that usual care should not be replaced by the minimal intervention.  
3.2.4 Manual therapy 
Ten studies evaluating some form of manual therapy were identified. Four of these studies were 
CUA and were conducted in the UK [22, 23, 36]. The study by Williams et al. [23] (UK, health care 
system) investigated the cost-utility of osteopathy clinic services within general practices in the UK, 
as compared to standard care. The authors found the osteopathy clinic intervention to result in 
higher health care system costs for an increase in health functioning, and estimated an ICER for 
osteopathy of £3,560 per QALY (valuation year: 1999). However, the authors caution that the 
conclusion “was subject to considerable random error” and highlight a need for further research to 
substantiate these results and assess the generalisability of the approach.  
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The UK BEAM Trial Team [22] (UK, health care system and patient perspective) compared a 12 week 
exercise programme and a spinal manipulation package, along with combined treatment, to a 
comparator of best care. Findings of the study suggested that the cost-effectiveness of each 
programme would depend on decision makers’ WTP for a QALY: if this value is much less than 
£3,800 (valuation year: 2000), ‘best care’ is likely to be the best strategy. If WTP lies between £3,800 
and £8,700, the optimal treatment would be spinal manipulation followed by exercise (i.e. the 
‘combined’ treatment). For WTP values well above £8,700, manipulation alone would be the most 
cost-effective treatment.  
Hollinghurst et al. [36] (UK, health care system, patient and societal perspectives) consider three 
single interventions (massage, Alexander technique and exercise), as well as five iterations of 
combined treatments, with normal care as the comparator. In terms of the single intervention, 
exercise performed best in terms of incremental cost-effectiveness (£2,847 per QALY, valuation year: 
2005). However, this was due to its low cost and it is noted that exercise performs badly in terms of 
pain free days. Among two-stage therapies, exercise combined with the Alexander technique was 
the optimal strategy (£5,332 per QALY). 
Haas et al. [24] (USA, perspective not explicitly stated) calculated the total healthcare costs in 
relation to Medicare expenditure for chiropractic care and found that this option was associated 
with only moderately higher total costs than usual care, mainly due to fewer onward/external 
referrals. The cost per reduction in pain and disability score for chiropractic care was lower for 
chronic than for acute patients. The intervention becomes more cost effective for chronic patients at 
12 months than at three months, though the opposite results are observed for acute patients.  
Niemisto et al. [21, 25] (Finland, societal perspective conducted a randomised controlled trial to 
compare physician consultation care combined with manipulative treatment and stabilising exercise 
against physician consultation. Findings were reported in two studies. The earlier of them [21] was 
based on 12 month follow up data and had a focus on the effectiveness of the treatments. The 
authors found no statistically significant differences in costs or health outcomes between the 
interventions, and calculated an additional cost of $23 per one-point change in a pain visual 
analogue scale associated with the combined intervention (valuation year: 2002). In the more recent 
study [25], the finding that a combination of manipulative treatment with exercises and physician 
consultation is cost-effective appears to reverse. Although there were still statistically significant 
differences in QoL between the combined intervention and physician consultation, these were 
deemed to be clinically minor and total annual cost savings were higher in the control.  
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Four studies investigated the effectiveness of acupuncture, three of which were cost-utility analyses 
measuring QALYs derived from the SF-6D tariff set. Ratcliffe et al. [26] (UK, health care system 
perspective) used data from a RCT to estimate the cost and QALYs associated with a programme of 
individualised acupuncture treatments delivered by acupuncturists trained in traditional Chinese 
medicine. The intervention was compared with usual care in the UK. The analysis showed 
acupuncture to be associated with increased costs (largely due to the initial cost of delivering 
acupuncture treatment), improved QoL and QALYs (mean incremental gain of 0.027 QALYs over 2 
years), and an ICER of £4241 per additional QALY gained (valuation year: 2002). Given the low 
additional cost for a modest improvement in QALYs, Ratcliffe and colleagues [26] suggest that, in the 
longer term, acupuncture care appears to be a cost-effective treatment for LBP.  
The most complex intervention involving acupuncture was evaluated by Herman et al. [35] (Canada, 
employer, participant and societal perspectives), who label as ‘naturopathic care’ a combination of 
acupuncture, exercise, dietary advice, relaxation training and education. Cost-effectiveness was 
calculated from three perspectives: societal, employer and participant. Findings suggested that 
naturopathic care was cost effective from all perspectives and was dominant from the societal 
perspective, compared to standardized physiotherapy education.  
In a study carried out in Germany, Witt et al. [30] (societal perspective) compared the provision of 
immediate acupuncture against delayed acupuncture, provided three months later. Two analyses 
were undertaken, the first on the basis of patients randomised to immediate or delayed 
acupuncture, and the second on the basis of patients who declined to be randomised and received 
immediate acupuncture. Data collected over a relatively short period of time (six months) showed 
immediate acupuncture to be cost-effective from a health service and societal perspective 
respectively.  
Kim et al. [40] (South Korea, societal perspective) sought to assess the cost-effectiveness of 
acupuncture as a complement to routine care in the treatment of chronic LBP in South Korea. To this 
end, the authors [40] developed a decision analytic model and populated it with cost and 
effectiveness information from the literature. Kim and colleagues [40] found acupuncture to result in 
improved QoL compared to usual care, for a modest increase in costs, a finding similar to Ratcliffe et 
al. [26]. The ICER for this comparison was calculated to be $2,759 per QALY gained (valuation year: 
2009).  
4. Discussion 
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This review identified 33 studies seeking to assess the costs and benefits of a wide range of non-
invasive and non-pharmacological interventions for LBP. Studies were grouped into four categories, 
according to the type of intervention they evaluated. The diversity of the interventions and the 
setting in which the assessment took place, and the often marked differences in the inputs and 
evaluation methods employed makes comparisons between studies, even within the same category, 
difficult. Nevertheless, the review offers insights into the cost-effectiveness of a wealth of 
interventions.  
4.1 Summary of findings 
Combined physical exercise and psychological treatments comprised the largest and the most 
diverse group of interventions. The group included studies which evaluated the use of the Keele risk 
stratification tool to target physiotherapy treatments [43, 45, 47, 50], as well as studies on group 
exercise and education sessions [33], pain-management programmes [31, 34], stabilisation 
physiotherapy [31]), multidisciplinary programmes with input from different health care 
professionals [19, 41, 42, 49] as well as a psychologist-led intervention [28]. With one exception [34], 
the interventions were compared to usual care and were found to be cost-effective [28, 31, 33, 41-
43, 45, 49]. In general, interventions were characterised by non-significant improvements in QALYs 
and modest increases in costs compared to comparators [31, 33, 34, 42, 43, 45, 47, 50], or the 
significance of these differences is not reported [41, 49].  
Findings of studies evaluating physical exercise therapy interventions are inconclusive, which may be 
partially explained by differences in the assessed programmes and employed methods. Studies 
assessing medical yoga showed this type of activity to be cost-effective from a payer’s perspective 
and suggest that it may result in averted loss of productivity [44, 48]. On the other hand, studies 
looking into structured exercise programmes are more cautious: although such programmes 
appeared to lead to small improvements in QoL, authors do not recommend their widespread use 
[27, 37-39]. In comparison to combined psychological and physical exercise interventions, physical 
exercise only interventions appear to be less cost-effective, but it would be interesting to see how 
the use of yoga, such as that described in the study by Chuang et al. [44], would compare to the 
interventions reported by Lamb et al. [41] and Foster et al. [47]. 
Studies evaluating interventions comprising provision of information and education are an equally 
diverse group. Interventions under assessment are usually multidisciplinary and comprise of clinical 
examination followed by information and advice. Three out of the five studies in this group employ 
CBA to estimate the benefit due to days on sick absence averted, net of the cost of the interventions 
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[18, 20, 46]. In general, interventions which have an ‘advice and information’ component appear to 
lead to reductions in absenteeism, which compensate for the modest increases in costs.  
Studies assessing the costs and benefits of manual therapy typically compare spinal manipulation 
alone or in combination with other components—most often exercise—against usual care, or 
acupuncture. Bar the studies by Niemisto and colleagues [21, 25], the non-acupuncture studies in 
this category suggest that manual therapy is a cost-effective alternative to usual care. Interestingly, 
Niemisto et al. [21] found that manipulative treatment is cost-effective as compared to usual care at 
12 months post intervention, but usual care becomes more cost-effective at the 2 year follow-up.  
On the whole, the identified evidence on acupuncture interventions is supportive of the idea that 
provision of acupuncture—either on its own, or in combination with usual care or other active 
treatments—improves LBP and is a cost-effective option. Three [26, 30, 40] of the four studies 
reported ICERs below the commonly cited threshold value of £20,000 per QALY, while the study by 
Herman et al. [35] found a multidisciplinary intervention that combines acupuncture with exercise 
and dietary advice, relaxation training and the provision of an educational booklet to be both less 
costly and more effective than standardised physiotherapy.  
The clinical recommendations for effective management of back pain advise an individualised multi-
modal package of care. A detailed bio-psychosocial assessment, including prognostic risk 
stratification, should inform targeted interventions. All patients will benefit from reassurance and 
advice and information on self-management. Further common interventions include physical activity 
and exercise programmes, manual therapy, with or without acupuncture, as part of a package of 
care empowering self-management but taking patient preference into account. Those with high risk 
stratification identifying barriers to recovery may benefit from more intensive intervention with a 
cognitive behavioural approach. While the clinical guidance for LBP is currently under review, the 
objective of this review is to assess cost-effectiveness, which does not imply clinical effectiveness. 
4.2 Methodological issues and comparability 
As mentioned above, various factors affect the quality of the identified studies and limit the extent 
to which reported results are comparable across, or even within, categories of interventions. 
Prominent amongst such factors are differences in the employed methods.  
A first factor that may limit the comparability between studies is the form of economic analysis 
employed. The choice between CEA, CUA, or CBA depends upon influences such as the requirements 
of local decision-making bodies, the funding and organisation of local health care services and to 
some extent the expertise and judgement of the research team. Thus, the use of different forms of 
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analysis poses difficulties in making direct comparisons of the results between studies. However, 
even when the same form of analysis is adopted, there are many aspects of study design which 
could, and do, vary.  For example, the results of any economic evaluation will differ if the primary 
measure of effect is changed [51, 52]. What has taken place in all of the studies reported, however, 
is a systematic comparison of alternative courses of action in terms of their costs and consequences. 
Hence, the headline findings of the different studies can be cautiously (with trends, patterns and 
contradictory findings highlighted) as a clear indication of the cost-effectiveness of the assessed 
interventions.  
A further noteworthy issue relates to the adopted perspective. While good practice guidelines for 
conducting economic evaluations recommend adoption of a wide perspective which will reflect costs 
incurred to the health care system, patients, their family and their carers, and the economy as a 
whole, many of the identified studies adopted narrower perspectives. This is likely to have been a 
pragmatic choice, dictated by the nature of the health care system in place and by the interest of 
decision makers who are likely to use the reported results. For example, studies conducted in the 
USA, such as those by Haas et al. [24], Strong et al. [29] and Norton et al. [49] were carried out from 
the perspective of the organisation that bears the cost, typically the insurer. In contrast, studies 
which were conducted in countries with public health care coverage, such as those by Whitehurst et 
al. [45], Chuang et al. [44] and Aboagye et al. [48], typically adopt a health care system (NHS) and 
societal perspective. 
Directly related to the chosen perspective is the inclusion of resource use and cost items in analyses. 
While good practice guidelines for conducting economic evaluations suggest that appraisal of 
interventions which are likely to affect absenteeism should include productivity costs [53, 54], there 
was considerable variation amongst studies in relation to the inclusion of such costs. The diversity in 
the resource use and costs included, as well as differences in sources of resource use and unit costs 
employed make comparisons of total costs between studies problematic. As private payments and 
productivity costs have been shown to constitute a significant share of the total cost of LBP [4, 55, 
56], the inclusion or exclusion of such costs in the analysis is expected to have a sizeable impact on 
results. Similarly, if included, the impact of private healthcare costs can be more influential than 
payer costs. In general, a range of different interventions are associated with modest impact on QoL, 
such that additional intervention costs, if any, are not sufficiently large to prevent the interventions 
from being cost-effective compared to usual practice. However, differences in treatment costs and 
QALYs tend not to be statistically significant when interventions are compared to usual care. In this 
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context decision-makers need to be aware of how local service activity and costs are likely to 
compare to those represented in the published studies.  
In relation to benefits, the identified studies employ a variety of health care measures to capture 
outcomes. These include a variety of condition and symptom specific measures about pain and 
disability, as well as QALYs. QALYs offer a generic measure of QoL that can facilitate comparisons, 
and this certainly has advantages over arguably narrower measures of outcome associated with 
CEAs. The multidimensional impact of LBP on people’s usual activities suggests that, in the future, 
there is potential to use other QoL measures, such as wellbeing and capability measures [57], which 
offer an opportunity to compare QoL more holistically than the ‘health’ focus of QALYs.  
Equally importantly, it must be noted that that evidence of cost-effectiveness does not necessarily 
imply clinical effectiveness [58]. Indeed there are many situations where intervention appear to 
result in clinical benefit, but economic analyses indicates that they are not cost-effective. 
Conversely, treatments which show little clinical benefit may result in cost savings that make them 
particularly appealing[58]. In addition, observing non-significant differences in QALYs (or costs) 
should not be interpreted as evidence of ‘no effect’, unless the study is specifically powered to 
detect such differences. Even if a study is suitably powered, it is widely agreed that, instead of 
focusing on hypothesis testing, conclusions about treatments’ cost-effectiveness should not be 
drawn from interpreting the key measure of interest and the uncertainty around it [15].Another 
factor which limits the accuracy of the reported aggregate value of health and economic outcomes, 
relates to the employed time horizon. The greatest share of studies were based on relatively short 
(typically 12 month) time horizons, which are likely to be inadequate in capturing the full extent of 
the long-term costs (or cost-savings) and benefits (or disbenefits) associated with treatments for 
LBP. Interestingly, in cases where a longer time horizon is adopted, this does affect the magnitude of 
the findings—and in the case of Niemisto et al. [25] it reversed the overall conclusion.  
Comparisons were also hindered by the way final results were presented across studies. While the 
majority of studies calculated and presented incremental cost-effectiveness ratios, not all of them 
explicated the uncertainty around these estimates. The likelihood of assessed interventions to be 
cost-effective at different WTP values was typically presented in later studies. It is clear that journals 
do not necessarily require researchers to adhere to publication guidelines for economic evaluations.  
All studies identified in this review were conducted in developed countries, mostly in North America, 
Western and Central Europe and Scandinavia. While, from a clinical perspective, populations in 
these countries can be expected to be similar and the effectiveness of treatments can be assumed to 
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be generalizable across countries, comparisons of cost-effectiveness results are likely to be 
unrealistic, given the considerable variability in the structure of health care systems, differences in 
the delivery and cost of health care services, and diversity in the bundle of services comprising usual 
care in different countries.  
4.3 Strengths and limitations 
The review poses particular strengths. In line with recommendations, we searched key electronic 
bibliographic databases and other sources, by constructing elaborate combinations of free text and 
indexing terms. Additional searches were carried out in reference lists of key known and identified 
references, including systematic reviews and official guidelines. Identified studies were 
independently assessed for inclusion against a set of predetermined criteria. No restrictions were 
applied on types of economic evaluation or analytic approach used: all types of full economic 
evaluations, as per the definition by Drummond et al. [15] were considered relevant, including both 
trial and model-based economic evaluation.  
Nonetheless, our review presents specific limitations. In order to narrow the wide range of possible 
non-invasive and non-pharmacological interventions, we looked into those interventions for which 
there are indications that are safe and potentially beneficial in guidelines by NICE and APA/ASC. This, 
however, may have led to the exclusion of interventions which are not mentioned in these 
guidelines. In addition, given the evolving nature of the interventions, and in the light of changes in 
the methodology used to assess them, we limited the review to studies published in the last 15 
years. This decision enabled us to reduce the chances of compromising comparability due to 
dissimilarities in the method of economic evaluations used, especially if such dissimilarities were 
introduced by studies assessing interventions which are now obsolete. While we have endeavoured 
to give authors’ conclusions around cost-effectiveness of interventions, in cases where judgements 
were needed on what may be perceived to be cost-effective, we based such judgements on 
indicative values of WTP for an additional QALY suggested by NICE in the UK. However, it is likely 
that WTP values may vary across countries.  
4.4 Comparison with other studies and future research 
Given the diverse nature of the interventions (exacerbated by the complex combinations of 
elements making up a single intervention) and the differences in the aims and scope of the included 
studies, the scope for comparison between our review and other studies is limited. The study that is 
deemed to be closest to our review in terms of its aims and focus is that of Lin et al. [59][]. The 
authors [59] concluded that the cost-effectiveness of advice as an intervention for LBP is unclear, but 
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other interventions, including interdisciplinary rehabilitation, exercise, acupuncture, spinal 
manipulation and cognitive-behavioural therapy were, in general, cost-effective for people with sub-
acute or chronic LBP. Findings in Lin et al. [59] and our review are in broad agreement. No studies 
evaluating the cost-effectiveness of medical yoga were identified or reported in the review by Lin et 
al. [59], though, in our review, we identified evidence which is supportive of yoga.  
4.5 Conclusions 
In summary, the reviewed evidence suggests that combined physical exercise and psychological 
treatments (CBT and risk stratification), provision of information, manual therapy (chiefly spinal 
manipulation and acupuncture) are cost-effective options for LBP. The identified evidence around 
physical exercise therapy is inconclusive; while medical yoga appears to be cost-effective compared 
to usual care, the finding for some active exercise programmes are equivocal. 
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Table 1. Consensus on Health Economic Criteria (CHEC) checklist [16] 
Study 
Item 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
Aboagye et al. [48] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y Y 
Chuang et al. [44] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y Y 
Critchley et al. [31] Y Y Y Y Y N N Y Y Y Y Y Y Y Y Y Y Y Y 
Foster et al. [47] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y Y 
Haas et al. [24] Y Y Y Y Y N N N Y Y Y Y Y N Y Y Y Y N 
Henchoz et al. [39] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y N Y 
Herman et al. [35] Y Y Y Y Y Y Y Y Y Y Y Y N N/A Y Y Y Y Y 
Hill et al. [43] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A N Y Y Y Y 
Hollinghurst et al. [36] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y Y 
Jellema et al. [32] Y Y Y Y Y Y Y Y Y Y Y Y Y Y N Y Y Y Y 
Jensen et al. [46] Y Y Y Y Y Y Y Y Y N N Y N N/A N Y Y Y Y 
Johnson et al. [33] Y Y Y Y Y N N N N Y Y Y Y N N N Y Y Y 
Kim et al. [40] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y N 
Lamb et al. [41] Y Y Y Y Y Y Y N Y Y Y Y Y N/A Y Y N Y Y 
Loisel et al. [18] Y Y Y Y Y Y Y Y Y N N N N N Y Y Y Y Y 
Molde Hagen et al. [20] Y Y Y Y Y Y Y Y Y Y Y Y N/A N/A N Y Y Y Y 
Niemisto et al. [21] Y Y Y Y Y Y Y Y Y Y Y N Y N/A N Y Y Y Y 
Niemisto et al. [25] Y Y Y Y Y Y Y Y Y Y Y Y Y N N Y Y Y N 
Norton et al. [49] Y Y Y Y Y Y Y N N Y Y Y Y Y Y Y N Y N 
30 
 
Ratcliffe et al. [26] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y N Y Y 
Rivero-Arias et al. [27] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y N 
Rogerson et al. [42] Y Y Y Y Y Y Y N Y Y Y Y Y N/A Y Y N N N 
Schweikert et al. [28] Y Y Y Y Y Y Y N Y Y Y Y Y N/A Y Y N Y Y 
Skouen et al. [19]. Y Y Y Y Y Y Y Y Y N Y Y N Y N Y Y Y Y 
Smeets et al. [38] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y Y 
Strong et al. [29] Y Y Y Y Y Y Y Y Y Y Y N/A Y N/A Y Y Y Y Y 
UK BEAM Trial team 
[22] 
Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y N Y Y 
van der Roer et al. [37] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y N Y Y 
Whitehurst et al. [34] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y N 
Whitehurst et al. [45] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y Y 
Whitehurst et al. [50] Y Y Y Y Y Y Y Y Y Y Y Y Y N/A Y Y Y Y Y 
Williams et al. [23] Y Y Y Y Y Y N N N Y Y Y Y N/A Y Y Y Y Y 
Witt et al. [30] Y Y Y Y Y Y N N N Y Y Y Y N/A N N Y Y Y 
Y: Yes; N: No; N/A: Not applicable. 
 
Item 1: Is the study population clearly described? Item 2: Are competing alternatives clearly described? Item 3: Is a well-defined research question posed in answerable 
form? Item 4: Is the economic study design appropriate to the stated objective? Item 5: Is the chosen time horizon appropriate to include relevant costs and 
consequences? Item 6: Is the actual perspective chosen appropriate? Item 7: Are all important and relevant costs for each alternative identified? Item 8: Are all costs 
measured appropriately in physical units? Item 9: Are costs valued appropriately? Item 10: Are all important and relevant outcomes for each alternative identified? Item 
11: Are all outcomes measured appropriately? Item 12: Are outcomes valued appropriately? Item 13: Is an incremental analysis of costs and outcomes of alternatives 
performed? Item 14: Are all future costs and outcomes discounted appropriately? Item 15: Are all important variables, whose values are uncertain, appropriately subjected 
to sensitivity analysis? Item 16: Do the conclusions follow from the data reported? Item 17: Does the study discuss the generalizability of the results to other settings and 
patient/ client groups? Item 18: Does the article indicate that there is no potential conflict of interest of study researcher(s) and funder(s)? Item 19: Are ethical and 
distributional issues discussed appropriately? 
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Table 2. Characteristics of included studies 
Study (year) Intervention(s) and comparator(s) Details of economic evaluation Resource use, costs and outcomes 
Combined physical exercise and psychological treatment 
Critchley et al. [31] (2007) Interventions: 
- Spinal stabilisation physiotherapy 
- Physiotherapist-led pain management 
programme informed by a cognitive-
behavioural approach 
 
Comparator: 
Usual outpatient physiotherapy 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
18 months 
 
Discounting: 
Yes (at 3.5% per year) 
 
Perspective:  
Health care system 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: pain 
management programme was dominant 
(CEAC 65% at £30,000) 
Foster et al. [47] (2014) and 
Whitehurst et al. [50] (2015) 
Intervention: 
Stratified care based on a risk stratification 
tool 
 
Comparator: 
Usual care 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
 Economic evaluation based on a ‘before-and-
after’ comparison of patient cohorts 
 
Time horizon:  
6 months 
 
Discounting: 
Not applicable 
 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services  
- Private  
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
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Perspective:  
- Health care system 
- Societal 
Incremental cost per QALY gained: 
Intervention was dominant (CEAC 
reported at risk-group level only) 
Hill et al. [43] (2011) and 
Whitehurst et al. [45] (2012) 
Intervention: 
Stratified care based on a risk stratification 
tool 
 
Comparator: 
Usual care 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Health care system 
Societal 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services 
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained:  
Intervention was dominant (CEAC 100% 
at £5,000) 
 
 
Johnson et al. [33] (2007) Intervention: 
Physiotherapist-led group programme of 
exercise and education sessions using a 
cognitive behavioural therapy approach 
 
Comparator(s): 
General practitioner-led usual care plus 
receipt of an educational pack 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
12 months 
 
Discounting: 
Not mentioned 
 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services 
- Private 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
£5,000 per QALY (CEAC 90% at £30,000) 
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Perspective: 
Health care system 
Lamb et al. [41] (2010) Intervention: 
Advice plus therapist-led assessment and 6 
sessions of group cognitive behavioural 
intervention 
 
Comparator: Usual care plus advice 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
12 months  
 
Discounting: 
Not applicable 
 
Perspective: 
Health care system 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services.  
 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
£1,786 per QALY (CEAC 90% at £3,000) 
 
Norton et al. [49] (2015) Intervention:  
Cognitive behavioural intervention from 
the Back Skills Training Trial reported by 
Lamb et al. [41] 
 
Comparator: 
Advice plus usual care from the Back Skills 
Training Trial reported by Lamb et al. [41] 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Economic evaluation based on a decision 
analytic model  
 
Country: 
USA 
 
Time horizon: 
12 months and 120 months.  
 
Discounting: 
Yes (3% per year) 
 
Perspective: 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
$7,197 per QALY over 12 months, 
$5,855 per QALY over 120 months 
(CEACs not reported) 
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Commercial payer 
Rogerson et al. [42] (2009) Intervention: 
Usual care plus multidisciplinary 
intervention consisting of 6 to 9 sessions of 
cognitive-behavioural and physical therapy 
 
Comparator: 
Usual care 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
USA 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Societal 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services. 
- Private payments 
- Income loss due to absence from paid 
employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (SF-6D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
intervention was dominant (CEAC 91% 
at $40,000) 
 
 
Schweikert et al. [28] (2006) Intervention: 
Usual care plus psychologist-led 6 sessions 
of group cognitive behavioural therapy. 
 
Comparator: 
Usual care comprising 3-week intensive 
inpatient intervention at a specialist clinic 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Germany 
 
Time horizon: 
6 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Societal 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services. 
- Private payments  
- Productivity loss due to absence from 
paid employment 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
intervention was dominant (CEAC not 
reported) 
 
35 
 
 
Skouen et al. [19] (2002) Interventions: 
- Advice about exercise, lifestyle & fear 
avoidance; - Extensive 4-week programme 
of cognitive behavioural modification and 
coping strategies support and daily physical 
exercise. 
 
Comparator: 
Usual care 
 
Type of economic evaluation: 
CBA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Norway 
 
Time horizon: 
24 months 
 
Discounting: 
Yes (3.5% per year) 
 
Perspective: 
Societal 
Main resource use items: 
- Intervention-related 
- Income loss due to absence from paid 
employment 
 
Measure of benefit used in economic 
evaluation: 
Return to paid work 
 
Main outcome of economic evaluation: 
Net benefit expressed in monetary 
terms: mean net productivity gain for 
advice intervention was US$14,947 per 
male patient over two years. No gain for 
female patients was found. 
 
Whitehurst et al. [34] (2007) Intervention: 
Physiotherapist-led pain management 
programme targeting psychosocial factors 
 
Comparator: 
Physiotherapist-led ‘best practice’ physical 
therapy 
 
Type of economic evaluation: 
- CUA 
- CEA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Health care system 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services. 
- Private payments  
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
£2,362 per QALY for physical therapy 
(CEAC 83% at £10,000) 
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Physical exercise interventions 
Aboagye et al. [48] (2015) Interventions: 
Medical yoga  
Exercise therapy 
 
Comparator: 
- Self-care advice 
 
 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Sweden 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
- Employer 
- Societal 
 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services 
- Productivity loss due to absence from 
paid employment 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
medical yoga was dominant vs exercise; 
EUR 4,167 per QALY for medical yoga  
vs self-care advice.  (CEACs not reported) 
Chuang et al. [44] (2012) Intervention: 
Yoga exercise plus usual care 
 
Comparator: 
Usual care 
 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Main resource use items: 
- Intervention-related costs 
- Primary care services 
- Secondary and specialist care services 
- Private  
- Productivity loss due to absence from 
paid employment 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
£13,606 per QALY vs usual care (CEAC 
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Perspective: 
- Health care system 
- Societal 
 
72% at £20,000) 
Henchoz et al. [39] (2010) Intervention(s): 
Post-rehabilitation exercise programme 
 
Comparator(s): 
Post-rehabilitation usual care 
 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Switzerland 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Societal 
Main resource use items: 
- Intervention-related costs 
- Primary care services 
- Secondary and specialist care services 
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (SF-6D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: EUR 
79,270 per QALY (CEAC not reported) 
Rivero-Arias et al. [27] (2006) Intervention(s): 
Physiotherapy treatment  
 
Comparator(s): 
Physiotherapist advice 
 
Type of economic evaluation: 
CUA 
 
Analytic method employed:  
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Main resource use items: 
- Intervention-related 
- Primary care services 
- Secondary and specialist care services 
- Private 
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
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Perspective: 
- Health care system 
- Societal 
 
£3,010 per QALY (CEAC 60% at £5,000 
willingness to pay, not rising above 73% 
for higher thresholds) 
van der Roer et al. [37] (2008) Intervention: 
Intensive group training 
 
Comparator: 
Usual care physiotherapy 
 
Types of economic evaluations: 
-CEA 
-CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Netherlands 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Societal 
 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services 
- Private 
- Informal care-related 
- Productivity loss due to absence from 
paid and unpaid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
- LBP-related disability (RMDQ) 
- Pain intensity (11-point numerical 
rating scale) 
- General perceived effect (6-point 
ordinal scale) 
- QALYs (EQ-5D) instrument. 
 
Main outcomes of economic 
evaluation:  
- Cost per 1-point improvement on the 
RMDQ 
- Cost per 1-point improvement on the 
pain intensity scale 
- Cost per 1-point improvement on the 
general perceived effect scale 
 - Incremental cost per QALY: EUR 5,141 
per QALY (CEAC not estimated) 
Smeets et al. [38] (2009) Interventions: 
- Active physical treatment  
- Graded Activity plus problem solving 
training 
Types of economic evaluation: 
- CEA 
- CUA 
 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services 
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- Combined treatment (i.e. active physical 
treatment and graded activity plus problem 
solving training) 
 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Netherlands 
 
Time horizon: 
15.5 months (62 weeks) 
 
Discounting: 
No 
 
Perspective: 
Societal 
 
- Private (including over-the-counter 
medications, equipment and aids, travel 
expenses, informal care and paid 
housekeeping) 
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used):  
- cost per reduction in LBP-related 
disability (RMDQ) 
- QALYs (EQ-5D) 
 
 
Main outcome of economic evaluation: 
- Incremental cost per 1-point 
improvement on the RMDQ 
- Incremental cost per QALY gained: 
graded activity plus problem solving 
training was dominant  compared to 
combination treatment (CEAC 
approximately 80% at EUR 20,000) 
Information and education intervention 
Loisel et al. [18] (2002) Interventions: 
- Clinical rehabilitation (comprising clinical 
examination, participation in back school 
and, if necessary, a multidisciplinary work 
rehabilitation intervention) 
- Occupational intervention (comprising 
visits to occupational medicine physician 
and participatory ergonomics intervention) 
- Sherbrooke model (comprising a 
combination of clinical rehabilitation and 
occupational intervention) 
 
Types of economic evaluation: 
-CBA 
-CEA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Canada 
 
Time horizon: 
12 months and total follow up period for each 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services  
 
Measure of benefit used in economic 
evaluation: 
- Benefit (avoided absence from paid 
employment) measured in monetary 
units. 
- Number of fully compensated days 
because of back pain 
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Comparator(s): 
Usual care 
 
 
participant (mean of 77 months (6.4 years)) 
 
Discounting: 
Not mentioned 
 
Perspective: 
Payer (insurance provider) 
 
Main outcome of economic evaluation: 
- Net benefit expressed in monetary 
units: all three interventions were 
associated with cost savings at 6.4 years 
compared to usual care.  The largest 
mean saving was $18,585 for the 
Sherbrooke model. 
- Cost per number of fully compensated 
days off work because of back pain: all 
three interventions were associated 
with a lower number of days on full 
benefits at 6.4 years compared to usual 
care.  The smallest cost per saved day on 
full benefits was -$88.40 for the 
occupational intervention. 
Molde Hagen et al. [20] 
(2003} 
Intervention: 
Spine clinic examination and provision of 
advice and information 
 
Comparator: 
Usual treatment in primary care 
Type of economic evaluation: 
CBA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Norway 
 
Time horizon: 
36 months (3 years) 
 
Discounting: 
Yes (3.5% per year) 
 
Perspective: 
Societal 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services  
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
Benefit due to avoided absence from 
paid employment measured in 
monetary units. 
 
Main outcome of economic evaluation: 
Net present value (i.e. difference 
between cost and benefit in monetary 
terms): mean net productivity gain for 
intervention was US$2,822 per patient 
over three years. 
Jensen et al. [46] (2013) Intervention: Type of economic evaluation: Main resource use items: 
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Clinical examination, guidance and tailored 
‘return-to-work’ programme.  
 
Comparator: 
Brief intervention involving clinical 
examinations by a rehabilitation doctor and 
a physiotherapist 
-CEA 
-CBA 
 
Analytic method employed:  
Trial-based economic evaluation 
 
Country: 
Denmark 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Health Care System 
Taxpayer  
Societal 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services. 
- Private (medicines) 
- Tax paid sick leave compensation 
 
Measure of benefit used in economic 
evaluation (instrument used): 
Employee sick leave averted 
 
Main outcome of economic evaluation: 
Incremental cost per 1 week averted 
sick leave 
Jellema et al. [32] (2007) Intervention: 
Minimal intervention strategy 
(identification and discussion of 
psychological prognostic factors) 
 
Comparator: 
Usual care 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Netherlands 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Societal 
Main resource use items: 
- Intervention-related 
- Primary care services 
- Secondary and specialist care services. 
- Private 
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
intervention was dominant for patients 
not at risk of losing their job. The ICER 
was EUR217 per week of sick leave 
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saved for patients who thought that 
they were at risk of losing their job. 
(CEAC not reported) 
 
Strong et al. [29] (2006) Interventions: 
- Self-management education led by a lay 
person; 
- Self-management education led by 
psychologist 
 
Comparator(s): 
Usual care plus a book on back pain care 
 
 
 
Type of economic evaluation: 
CEA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
USA 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Insurer (health care plan) 
Main resource use items: 
- Intervention-related 
- Primary care services 
- Secondary and specialist care services 
 
Measure of benefit used in economic 
evaluation: 
Number of low-impact back pain days 
 
Main outcome of economic evaluation: 
Incremental cost per additional low-
impact back pain day: $9.70 per low-
impact back pain day for the lay 
intervention, and $6.13 per low-impact 
back pain day for the psychologist 
intervention.  (CEACs not reported) 
 
Manual therapy interventions 
Haas et al. [24] (2005) Intervention: 
Chiropractic care (spinal manipulation), 
exercise plan and self-care education 
 
Comparator: 
Usual medical care (including exercise plan 
and self-care education) 
 
 
Type of economic evaluation: 
CEA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
USA 
 
Time horizon: 
12 months  
 
Discounting: 
Main resource use items: 
- Secondary and specialist care services 
(Medicare) 
 
Measure of benefit used in economic 
evaluation (instrument used): 
Pain, functional disability, patient 
satisfaction, physical health, mental 
health via a Visual Analogue Scale, the 
Revised Oswestry Disability 
Questionnaire and the Short Form 12 
questionnaire. 
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Not applicable 
 
Perspective: 
Health provider (not explicitly stated) 
 
Main outcome of economic evaluation: 
Additional cost per improvement in 
clinical outcomes: Chronic cohort: $0.1 
incremental total cost per unit of 
improvement in the pain measure at 12 
months.  Acute cohort: $12 incremental 
total cost per unit of improvement in 
the pain measure at 12 months. 
Hollinghurst et al. [36] (2008) Intervention(s): 
- Therapeutic massage; 
- Therapeutic massage plus exercise 
prescription 
- Alexander technique (6 or 24 lessons); 
- Alexander technique (6 or 24 lessons) plus 
exercise prescription 
- Usual care plus exercise prescription 
 
Comparator(s): 
Usual care 
 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
- Patient 
- Health care system 
- Societal 
 
Main resource use items: 
- Intervention-related 
- Primary care services 
- Secondary and specialist care services. 
- Private  
- Loss of earnings 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D). 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
£5,332 per QALY for Alexander 
technique (6 lessons) plus exercise 
prescription compared to normal care 
plus exercise (CEAC 85% at £20,000) 
Niemisto et al. [21, 25] (2003, 
2005) 
Intervention(s): 
Physician consultation plus 4 sessions of 
combined manipulation and stabilisation 
exercises 
 
Comparator(s): 
Physician consultation alone plus an 
educational booklet 
Type of economic evaluation: 
CEA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Finland 
Main resource use items: 
- Primary care services 
- Secondary and specialist care services. 
- Private  
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
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Time horizon: 
12 months [21] and 24 months [25]. 
 
Discounting: 
Not applicable 
 
Perspective: 
Societal 
evaluation (instrument used): 
Pain (VAS), disability (Oswestry Low 
Back Pain Disability Questionnaire), 
mental depression (Finnish Depression 
Questionnaire), health related quality of 
life (15D), days on sick leave. 
 
Main outcome of economic evaluation: 
Additional cost per one- point change in 
pain score obtained from a visual 
analogue scale: a one-point increase in 
the intervention group compared to the 
control group in the VAS cost $512 
(CEAC 75% at $2,100 for a one-point 
increase in VAS) 
UK BEAM Trial Team [22] 
(2004) 
Intervention(s): 
- ‘Best care’ plus exercise; 
- ‘Best care’ plus spinal manipulation; 
- ‘Best care’ plus spinal manipulation 
followed by exercise (combined treatment) 
 
Comparator(s): 
- ‘Best care’ in general practice 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
12 months 
 
Discounting: 
Not applicable 
 
Perspective: 
- Health care system 
- Patient payments 
 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services. 
- Private  
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D). 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
£8,700 for spinal manipulation relative 
to spinal manipulation followed by 
exercise (CEAC 50% at £15,000) 
Williams et al. [23] (2004) Intervention(s): 
Osteopathy clinic (3 or 4 sessions) plus 
Type of economic evaluation: 
CUA 
Main resource use items: 
- Intervention-related  
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usual general practitioner care 
 
Comparator(s): 
Usual care (general practice) 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
UK 
 
Time horizon: 
6 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Health care provider 
 
- Primary care services 
- Secondary and specialist care services. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (EQ-5D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
£3,560 per QALY (CEAC approximately 
85% at £20,000) 
Ratcliffe et al. [26] (2006) Intervention: 
Acupuncture treatment 
 
Comparator: 
Usual care 
 
 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country:  
UK 
 
Time horizon: 
24 months 
 
Discounting: 
Yes (at 3.5% per year) 
 
Perspective:  
Health care system 
Societal 
Main resource use items: 
- Intervention-related 
- Primary care services 
- Secondary and specialist care services.  
- Private 
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (SF-6D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained 
 
Witt et al. [30] (2006) Intervention: 
Immediate access to acupuncture 
Type of economic evaluation: 
CUA 
Main resource use items: 
- Intervention-related costs  
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Comparator: 
Acupuncture offered with a 3 month delay. 
 
 
 
Analytic method employed: 
Economic evaluation based on randomised and 
nonrandomised studies 
 
Country: 
Germany 
 
Time horizon: 
6 months 
 
Discounting: 
Not applicable 
 
Perspective: 
Societal 
- Use of primary care services 
- Use of secondary and specialist care 
services.  
- Private (out-of-pocket) payments 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (SF-6D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: EUR 
10,526 per QALY (CEAC approximately 
100% at EUR 30,000) 
Herman et al. [35] (2008) Intervention: 
Neuropathic care, including acupuncture, 
relaxation exercises, exercise, dietary 
advice and a back care booklet.  
 
Comparator: 
Standardised physiotherapy education and 
a back care booklet 
 
 
Type of economic evaluation: 
CUA 
 
Analytic method employed: 
Trial-based economic evaluation 
 
Country: 
Canada 
 
Time horizon: 
6 months 
 
Discounting: 
Not applicable 
 
Perspective: 
- Employer 
- Participants 
- Society 
Main resource use items: 
- Intervention-related  
- Primary care services 
- Secondary and specialist care services.  
- Productivity loss due to absence from 
paid employment. 
 
Measure of benefit used in economic 
evaluation (instrument used): 
QALY (SF-6D) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: 
intervention was dominant (CEAC not 
reported) 
Kim et al. [40] (2010) Intervention: Type of economic evaluation: Main resource use items: 
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Acupuncture in addition to usual care 
 
Comparator: 
Usual care  
 
 
CUA 
 
Analytic method employed: 
Economic evaluation based on a decision 
analytic model 
 
Country: 
South Korea 
 
Time horizon: 
72 months 
 
Discounting: 
Yes (5% per year) 
 
Perspective: 
Societal 
 
- Intervention-related costs  
- Primary care services 
- Secondary and specialist care services.  
- Private 
- Productivity loss due to absence from 
paid employment 
 
Measure of benefit used in economic 
evaluation (instrument): 
QALY (estimated using SF-6D values 
from Witt et al. [30]) 
 
Main outcome of economic evaluation: 
Incremental cost per QALY gained: KRW 
3,421,394 ($2,896) per QALY (CEAC 72% 
at KRW 20,000,000 ($16,935) 
QALY: quality-adjusted life year; CEA: cost-effectiveness analysis; CUA: cost-utility analysis; CBA: cost-benefit analysis; EQ-5D: EuroQol 5D (3-level) instrument; SF-6D: Short 
Form 6D instrument; RMDQ: Roland Morris disability questionnaire 
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Figure 
Figure 1. PRISMA flow diagram depicting the process of record identification, screening and study 
inclusion 
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Records identified through 
database searching 
(n = 1265) 
 
Additional records identified 
through other sources 
(n = 20) 
 
Similar articles searches: 9 
Reference list scanning: 11 
Records after duplicates removed 
(n = 891 ) 
Records excluded 
(n = 802) 
Full-text articles 
assessed for eligibility 
(n = 89) 
Full-text articles 
excluded  
(n=56)  
 
Reason: article did not meet 
one or more of the inclusion 
criteria: 
 
Irrelevant population: 16 
Irrelevant intervention: 10 
Not full economic evaluation: 
17 
Other reason (e.g. conference 
abstract, letter, same study 
published in different journals): 
13 
 
Studies included the 
systematic review (n = 
33) 
Figure 1. PRISMA flow diagram depicting the process of record identification, screening and study inclusion 
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Appendices and online materials 
Online Resource 1: Table 1. Categorisation of interventions 
Online Resource 1: Search strategy used in MEDLINE 
Online Resource 1: Table 2. Inclusion and exclusion criteria 
 
Online Resource 1.  
Table 1. List of non-invasive and non-pharmacological interventions.  
Intervention category Examples of relevant treatments 
Combined physical exercise and 
psychological  
Cognitive behavioural therapy 
c
 
Interdisciplinary rehabilitation 
b
 
Physical exercise therapy Aerobic activity 
c
 
Movement instruction 
a
 
Muscle strengthening 
c
 
Postural control 
a
 
Stretching 
c
 
Yoga 
b
 
Superficial heat 
b
  
Progressive relaxation 
b
 
Functional restoration 
b
  
Manual therapy Spinal manipulation 
c
 
Spinal mobilisation 
a
 
Massage 
c
  
Acupuncture 
c
 
Information and education Advice & information on self-management 
a
 
a
 Included in NICE guideline [13] only; b Included in APS/ASC guideline [10] only; 
c 
Included in both NICE and 
APS/ASC guidelines 
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Online Resource 1.  
Search strategy used in MEDLINE 
1. low back pain/ or low back pain.ti,ab. 
2. lumbago/ or lumbago.ti,ab. 
3. backache/ or backache.ti,ab. 
4. dorsalgia/ or dorsalgia.ti,ab. 
5. lower back pain/ or lower back pain.ti,ab. 
6. lumbar pain/ or lumbar pain.ti,ab. 
7. back pain/ or back pain.ti,ab. 
8. spin* disease*/ or spin* disease*.ti,ab. 
9. coccydynia/ or coccydynia.ti,ab. 
10. spinal pain/ or spinal pain.ti,ab. 
11. dorsopathy/ or dorsopathy.ti,ab. 
12. lumbar disease*/ or lumbar disease*.ti,ab. 
13. back disorder*/ or back disorder*.ti,ab. 
 
14. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 
 
15. health econom*.ti,ab. 
16. economic* evaluation*.ti,ab. 
17. economic* analys#s.ti,ab. 
18. cost effect*.ti,ab. 
19. cost-effect*.ti,ab. 
20. cost benefit*.ti,ab. 
21. cost-benefit*.ti,ab. 
22. cost utilit*.ti,ab. 
23. cost-utilit*.ti,ab. 
24. cost consequence* analys#s.ti,ab. 
25. cost-consequence* analys#s.ti,ab. 
26. cost minimi#ation analys#s.ti,ab. 
27. cost-minimi#ation analys#s.ti,ab. 
28. economic* aspect*.ti,ab. 
29. health care cost*.ti,ab. 
30. cost analys#s.ti,ab. 
 
31. 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 
 
32. advice.ti,ab. 
33. information.ti,ab. 
34. educat*.ti,ab. 
35. physical activit*.ti,ab. 
36. exercise*.ti,ab. 
37. aerobic exercise*.ti,ab. 
38. aerobic activit*.ti,ab. 
39. movement* instruction*.ti,ab. 
40. muscle strengthen*.ti,ab. 
41. postural control.ti,ab. 
42. stretching.ti,ab. 
43. manual therap*.ti,ab. 
44. spinal manipulation*.ti,ab. 
45. spinal mobili#ation*.ti,ab. 
46. massage.ti,ab. 
47. acupuncture.ti,ab. 
48. psychotherap*.ti,ab. 
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49. psychological therap*.ti,ab. 
50. psychological treatment*.ti,ab. 
51. psychological intervention*.ti,ab. 
52. cognitive therap*.ti,ab. 
53. cognitive treatment*.ti,ab. 
54. cognitive intervention*.ti,ab. 
55. behaviour therap*.ti,ab. 
56. behaviour treatment*.ti,ab. 
57. behaviour intervention*.ti,ab. 
58. behavior therap*.ti,ab. 
59. behavior treatment*.ti,ab. 
60. behavior intervention*.ti,ab. 
61. cognitive behavior*.ti,ab. 
62. cognitive behaviour*.ti,ab. 
63. cognitive behavioral therap*.ti,ab. 
64. cognitive behavioural therap*.ti,ab. 
65. CBT.ti,ab. 
66. progressive relaxation*.ti,ab. 
67. interdisciplinary rehabilitation.ti,ab. 
68. functional restoration*.ti,ab. 
69. superficial heat.ti,ab. 
 
70. 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 
or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 
 
71. 14 and 31 and 70 
 
72. limit 71 to English 
73. limit 72 to yr="2000 -Current" 
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Online Resource 1.  
Table 2. Inclusion and exclusion criteria 
Aspect Inclusion criteria 
Population Human subjects with non-specific acute, sub-acute or chronic low back pain. 
Intervention Non-pharmacological interventions specified in the National Institute for Health and 
Care Excellence guideline [56] for early management of low back pain and in the 
American Pain Society/American College of Physicians clinical guidelines [10]. 
Comparator(s) Any comparators, including:  
 ‘do nothing’/placebo/sham interventions  
 pharmacological interventions 
 surgery, and/or  
 other non-pharmacological interventions 
Outcomes Cost per-unit of effect (e.g., natural unit, quality-adjusted life year), presented as 
either a summary measure or in a disaggregated form. 
Study design Cost-effectiveness analysis, cost-benefit analysis, cost-utility analysis, cost-
consequences analysis or cost-minimisation analysis. 
Other restrictions Published between January 2000 to July 2015.  
Published in English 
 
 
